Abstract
Suvorexant is a new insomnia drug, and it is generally safe and well tolerated. Here, we report a rare but potentially important adverse effect of suvorexant in a patient with Parkinson disease.
Author supplied keywords
Cite
CITATION STYLE
APA
Tabata, H., Kuriyama, A., Yamao, F., Kitaguchi, H., & Shindo, K. (2017). Suvorexant-induced dream enactment behavior in Parkinson disease: A case report. Journal of Clinical Sleep Medicine, 13(5), 759–760. https://doi.org/10.5664/jcsm.6600
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free